These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21756849)

  • 1. The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies.
    Al-Serri A; Anstee QM; Valenti L; Nobili V; Leathart JB; Dongiovanni P; Patch J; Fracanzani A; Fargion S; Day CP; Daly AK
    J Hepatol; 2012 Feb; 56(2):448-54. PubMed ID: 21756849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.
    Valenti L; Nobili V; Al-Serri A; Rametta R; Leathart JB; Zappa MA; Dongiovanni P; Fracanzani AL; Alterio A; Roviaro G; Daly AK; Fargion S; Day CP
    J Hepatol; 2011 Dec; 55(6):1409-14. PubMed ID: 21777557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease].
    Xu J; Xin YN; Lü WH; Lin ZH; Zhang DD; Zhang M; Dong QJ; Jiang XJ; Xuan SY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):619-23. PubMed ID: 24119744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease.
    Zain SM; Mohamed R; Mahadeva S; Cheah PL; Rampal S; Basu RC; Mohamed Z
    Hum Genet; 2012 Jul; 131(7):1145-52. PubMed ID: 22258181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis.
    Namikawa C; Shu-Ping Z; Vyselaar JR; Nozaki Y; Nemoto Y; Ono M; Akisawa N; Saibara T; Hiroi M; Enzan H; Onishi S
    J Hepatol; 2004 May; 40(5):781-6. PubMed ID: 15094225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study.
    Vespasiani-Gentilucci U; Dell'Unto C; De Vincentis A; Baiocchini A; Delle Monache M; Cecere R; Pellicelli AM; Giannelli V; Carotti S; Galati G; Gallo P; Valentini F; Del Nonno F; Rosati D; Morini S; Antonelli-Incalzi R; Picardi A
    Can J Gastroenterol Hepatol; 2018; 2018():7564835. PubMed ID: 29732362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
    Wang CW; Lin HY; Shin SJ; Yu ML; Lin ZY; Dai CY; Huang JF; Chen SC; Li SS; Chuang WL
    Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study.
    Uygun A; Ozturk K; Demirci H; Oztuna A; Eren F; Kozan S; Yilmaz Y; Kurt O; Turker T; Vatansever S; Alper E; Unsal B
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):441-447. PubMed ID: 28253210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.
    Lin YC; Chang PF; Hu FC; Yang WS; Chang MH; Ni YH
    J Pediatr; 2011 May; 158(5):740-4. PubMed ID: 21168155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
    Valenti L; Alisi A; Galmozzi E; Bartuli A; Del Menico B; Alterio A; Dongiovanni P; Fargion S; Nobili V
    Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients.
    Vespasiani-Gentilucci U; Gallo P; Porcari A; Carotti S; Galati G; Piccioni L; De Vincentis A; Dell'Unto C; Vorini F; Morini S; Riva E; Picardi A
    Scand J Gastroenterol; 2016 Aug; 51(8):967-73. PubMed ID: 27150500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population.
    Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L
    Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma.
    Brown AL; Lupo PJ; Okcu MF; Lau CC; Rednam S; Scheurer ME
    Cancer Med; 2015 Nov; 4(11):1679-86. PubMed ID: 26400460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease.
    Kitamoto T; Kitamoto A; Ogawa Y; Honda Y; Imajo K; Saito S; Yoneda M; Nakamura T; Nakajima A; Hotta K
    J Hepatol; 2015 Aug; 63(2):494-502. PubMed ID: 25776890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Al-Serri A; Daly AK; Galmozzi E; Rametta R; Dongiovanni P; Nobili V; Mozzi E; Roviaro G; Vanni E; Bugianesi E; Maggioni M; Fracanzani AL; Fargion S; Day CP
    Hepatology; 2010 Apr; 51(4):1209-17. PubMed ID: 20373368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene.
    Tan HL; Zain SM; Mohamed R; Rampal S; Chin KF; Basu RC; Cheah PL; Mahadeva S; Mohamed Z
    J Gastroenterol; 2014 Jun; 49(6):1056-64. PubMed ID: 23800943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity.
    Sookoian S; Castaño GO; Scian R; Mallardi P; Fernández Gianotti T; Burgueño AL; San Martino J; Pirola CJ
    Hepatology; 2015 Feb; 61(2):515-25. PubMed ID: 25302781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH).
    Mehta R; Jeiran K; Koenig AB; Otgonsuren M; Goodman Z; Baranova A; Younossi Z
    BMC Med Genet; 2016 Sep; 17(1):63. PubMed ID: 27596100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.
    Kawaguchi T; Sumida Y; Umemura A; Matsuo K; Takahashi M; Takamura T; Yasui K; Saibara T; Hashimoto E; Kawanaka M; Watanabe S; Kawata S; Imai Y; Kokubo M; Shima T; Park H; Tanaka H; Tajima K; Yamada R; Matsuda F; Okanoue T;
    PLoS One; 2012; 7(6):e38322. PubMed ID: 22719876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
    Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.